BKYI vs. MYSZ, TAOP, BCAN, IFBD, WAVD, AMST, SYTA, GROM, RBCN, and WTRH
Should you be buying BIO-key International stock or one of its competitors? The main competitors of BIO-key International include My Size (MYSZ), Taoping (TAOP), BYND Cannasoft Enterprises (BCAN), Infobird (IFBD), WaveDancer (WAVD), Amesite (AMST), Siyata Mobile (SYTA), Grom Social Enterprises (GROM), Rubicon Technology (RBCN), and ASAP (WTRH).
My Size (NASDAQ:MYSZ) and BIO-key International (NASDAQ:BKYI) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation, institutional ownership and community ranking.
BIO-key International has a net margin of -90.82% compared to BIO-key International's net margin of -117.08%. My Size's return on equity of -136.97% beat BIO-key International's return on equity.
BIO-key International received 132 more outperform votes than My Size when rated by MarketBeat users. However, 73.68% of users gave My Size an outperform vote while only 66.67% of users gave BIO-key International an outperform vote.
My Size has higher earnings, but lower revenue than BIO-key International. My Size is trading at a lower price-to-earnings ratio than BIO-key International, indicating that it is currently the more affordable of the two stocks.
My Size has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, BIO-key International has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500.
In the previous week, My Size had 4 more articles in the media than BIO-key International. MarketBeat recorded 6 mentions for My Size and 2 mentions for BIO-key International. My Size's average media sentiment score of 0.33 beat BIO-key International's score of 0.00 indicating that BIO-key International is being referred to more favorably in the news media.
My Size currently has a consensus target price of $12.00, suggesting a potential upside of 234.26%. Given BIO-key International's higher probable upside, equities research analysts clearly believe My Size is more favorable than BIO-key International.
27.7% of My Size shares are held by institutional investors. Comparatively, 26.5% of BIO-key International shares are held by institutional investors. 5.8% of My Size shares are held by company insiders. Comparatively, 13.7% of BIO-key International shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
BIO-key International beats My Size on 9 of the 17 factors compared between the two stocks.
Get BIO-key International News Delivered to You Automatically
Sign up to receive the latest news and ratings for BKYI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BKYI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BIO-key International Competitors List
Related Companies and Tools
